Morales, Anecita .
HRN: 29-11-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/14/2026
07/21/2026
IV
600mg
Q8h
Nonhealing Wound, Right Leg
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes